Characterization of a MnII complex of Alizarin suggests attributes explaining a superior anticancer activity: A comparison with anthracycline drugs.

MLA

Saha, Mouli, et al. “Characterization of a MnII Complex of Alizarin Suggests Attributes Explaining a Superior Anticancer Activity: A Comparison with Anthracycline Drugs.” Polyhedron, vol. 173, Nov. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.poly.2019.08.007.

APA

Saha, M., Singha, S., Chakraborty, M., Mazumdar, S., Kumar, S., Karmakar, P., & Das, S. (2019). Characterization of a MnII complex of Alizarin suggests attributes explaining a superior anticancer activity: A comparison with anthracycline drugs. Polyhedron, 173, N.PAG. https://doi.org/10.1016/j.poly.2019.08.007

Chicago

Saha, Mouli, Soumen Singha, Mousumi Chakraborty, Swagata Mazumdar, Sanjay Kumar, Parimal Karmakar, and Saurabh Das. 2019. “Characterization of a MnII Complex of Alizarin Suggests Attributes Explaining a Superior Anticancer Activity: A Comparison with Anthracycline Drugs.” Polyhedron 173 (November): N.PAG. doi:10.1016/j.poly.2019.08.007.